SARS-CoV-2 Orf1ab Genome Mutations, the Driving Force for Virus Pathogenicity.
Main Article Content
Abstract
Background: The proteins codified in the Open Reading Frame 1ab -Orf1ab- region of the SARS-CoV-2 genome are the main responsible of the virus transcription, replication, and translation processes inside the human cell.
Once inside the cell, the viral mRNA encode structural and nonstructural proteins, that direct virus assembly, transcription, replication and host control, and the accessory proteins whose function has not been determined.
The largest gene, Orf1ab, contains overlapping open reading frames that encode polyproteins PP1ab and PP1a.
These polyproteins are cleaved to yield 16 nonstructural proteins, NSP1-16.
Production of the longer (PP1ab) or shorter protein (PP1a) depends on a ribosomal frameshifting event.
The proteins, include the papain-like proteinase (NSP3), 3C-like proteinase (NSP5), RNA-dependent RNA polymerase (NSP12, RdRp), helicase (NSP13, HEL), endoRNAse (NSP15), 2'-O-Ribose-Methyltransferase (NSP16) and other nonstructural proteins.
The SARS-CoV-2 nonstructural proteins are responsible for viral transcription, replication, proteolytic processing, suppression of host immune responses, and suppression of host gene expression.
The purpose of the manuscript is to present a systematic review as of September 30, 2023, on the Orf1ab region mutations of the SARS-CoV-2 genome as of September 30, 2023, with the aim to predict, through the mutations profile on that region, the severity of an infection for a new SARS-CoV-2 variant that could emerge in the near future.
Material and Methods: Original scientific articles published in Medline, Pubmed, Science Direct, Web of Science, Scopus, EBSCO and BioMed Central databases, official health organizations (WHO, CDC, ECDEC, NIH) electronic publications, and specialized media in the subject, were electronically searched to accomplish the aim of the study.
Articles published in any language were included from 2020 to present using a variety of keywords in combination.
The studies relevant to our review were analysed and compared.
Results and discussion: The NIH “National Human Genome Research Institute” define the Open Reading Frames (ORFs) as a portion of a DNA sequence that does not include a stop codon.
The Open Reading Frames encode accessory proteins transcribed from the 3′ one-third of the genome to form a set of subgenomic mRNAs (sg mRNAs).
Following entry on the human cell, the viral particle release the genomic RNA molecule that is translated on two large open reading frames, ORF1a and ORF1b.
The resulting polyproteins pp1a and pp1ab are co-translationally and post-translationally processed into the individual non-structural proteins (NSPs) that form the viral replication and transcription complex (RTC).
Translated structural proteins translocate into endoplasmic reticulum (ER) membranes and transit through the ER-to-Golgi intermediate compartment (ERGIC), where interaction with N-encapsidated, newly produced genomic RNA results in budding into the lumen of secretory vesicular compartments.
Two viral proteases, Plpro -NSP3- and 3Cl-pro -NSP5-, process the polyproteins and generate the nonstructural proteins NSP1-NSP16 that directs the transcription, replication and construction of new virions that are secreted by exocytosis from the infected cell.
The evolution of key proteins in viral transcription and replication is clearly observed by carefully studying the structure, function, and evolution of RdRp, Mpro or 3Clpro, and NSP13 proteins directed by the Orf1a and Orf1ab genome mutations.
Conclusions: ORF1ab is cleaved into 16 non-structural proteins involved in SARS-CoV-2 transcription and genome replication.
P323L, P227L, G671S, V776L and A185S are the first five frequent mutations of RdRp (NSP12), the mutations P227L and G671S might have functional consequences in the viral transcription and replication.
Mutations in residues D499 to L514, K545, R555, T611 to M626, G678 to T710, S759 to D761 are directly implicated with the transcription-replication capability of the virus by RdRp.
In Mpro (NSP5) the mutation of residues H41, P132, C145, S145, L226, T234, R298, S301, F305, and Q306 may increase the efficiency of proteolytic cleavage of proteins such as NEMO, thereby improving the ability of the omicron series of viruses to suppress the immune system and accelerate the viral replication.
In Helicase (NSP13) the mutations of residues E261, K218, K288, S289, H290, D374, E375, Q404, K460, R567, and A598 are involved in the separation of the double-stranded RNA or DNA with a 5′→3′ polarity as well as 5′ mRNA capping activity in the virus transcription-replication process.
In the Orf1ab gene, ORF1b:V2354F mutation, corresponding to NSP15:V303F, may induce a conformational change and result in a disruption to a flanking beta-sheet structure.
The premature stop codon ORF7a:Q94*, truncates the transmembrane protein and cytosolic tail used to mediate protein transport, may affect protein localization to the ER-Golgi.
The analyses of Orf1ab genome mutations, allows us to predict, through the mutations profile on that region, the severity of an infection for a new SARS-CoV-2 variant that could emerge in the near future.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. V’kovski Ph, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nature Reviews Microbiology. 2021. 19:155-170. https://doi.org/10.1038/s41579-020-00468-6
3. Huang J, Song W, Huang H, Sun Q. Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19. Journal of Clinical Medicine. 2020; 9(4):1131. https://doi.org/10.3390/jcm9041131
4. Islam J, Islam NN, Alom S, Kabir M, Halim MA. A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites. Immunobiology. 2023; 228(1):152302. https://doi.org/10.1016/j.imbio.2022.152302
5. Chen J, Malone B, Llewellyn E, Grasso M, Shelton PMM, et al. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex. Cell. 2020; 182:1560-1573. https://doi.org/10.1016/J.CELL.2020.07.033
6. Lu R, Zhao X, Li J, Niu P, Yang B, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020; 395:565-574.
7. Protein Data Bank data base: https://rcsb.org/covid19
8. Mazhari S, Alavifard H, Rahimian K, Karimi Z, Mahmanzar M, et al. SARS-CoV-2 NSP-12 mutations survey during the pandemic in the world. Research Square. 2021. https://doi.org/10.21203/rs.3.rs-877078/v1
9. Gao Y, Yan L, Huang Y, Liu F, Zhao Y, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020; 368:779-782. http://doi.org/10.1126/science.abb 7498
10. Becerra-Flores M, Cardozo T. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate. International journal of clinical practice. 2020; 74:e13525. https://doi.org/10.1111/ijcp.13525
11. Ilmjärv S, Abdul F, Acosta-Gutiérrez S, Estarellas C, Galdadas L, et al. concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant. Scientific Reports. 2021; 11:13705. https://doi.org/10.1038/s41598-021-91662-w
12. Wang Q, Wu J, Wang H, Gao Y, Liu Q, et al. Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase. Cell. 2020; 182:417-428.https://doi.org/10.1016/j.cell.2020.05.034
13. Venkataraman S., Prasad BVLS, Selvarajan R. RNA dependent RNA polymerases: insights from structure. function and evolution. Viruses. 2018; 10(2):76. https://doi.org/10.3390%2Fv10020076
14. Hillen HS, Kokic G, Farnung L, Dienemann Ch, Tegunov D, et al. Structure of Replicating SARS-CoV-2 Polymerase. Nature. 2020; 584:154-156. https://doi.org/10.1038/s41586-020-2368-8
15. Kirchdoerfer RN, Ward AB. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nature Communications. 2019; 10:2342. https://doi.org/10.1038/s41467-019-10280-3
16. Jiang, Y, Yin W, Xu H. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19. Biochemical and Biophysical Research Communications. 2021; 538:47-53. https://doi.org/10.1016%2Fj.bbrc.2020.08.116
17. Pachetti M, Marini B, Benedetti F, Giudici F, Mauro E, et al. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. Journal of Translational Medicine. 2020; 18:179. https://doi.org/10.1186/s12967-020-02344-6
18. Eskier D, Karakülah G, Suner A, Oktay Y. RdRp Mutations are Associated with SARS-CoV-2 Genome Evolution. PeerJ Microbiology. 2020; 8:e9857. https://doi.org/10.7717/peerj.9587
19. Yin W, Mao Ch, Luan X, Shen DD, Shen Q, et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science. 2020; 368: 1499-1504. https://doi.org/10.1126/science.abc1560
20. Koudelka T, Boger J, Henkel A, Schönherr R, Krantz R, et al. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease. Proteomics. 2020; 21(2): 20246.https://doi.org/10.1002/pmic.202000246
21. Zhang L, Lin D, Sun X, Curth U, Drosten Ch, et al. Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved a-Ketoamide Inhibitors. Science. 2020; 368:409-412. https://doi.org/10.1126/science.abb3405
22. Cooper MS, Zhang L, Ibrahim M, Zhang X, Sun X, et al. Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease. Journal of Medicinal Chemistry. 2022; 65(19):13328-13342. https://doi.org/10.1021/acs.jmedchem.2c01131
23. Hameedi MA, Prates ET, Garvin MR, Mathews II, Amos BK, et al. Structural and functional characterization of NEMO cleavage by SARS-CoV-2 3CLpro. Nature Communications. 2022; 13:5285. https://doi.org/10.1038/s41467-022-32922-9
24. Rothwarf DM, Zandi E, Natoli G, Karin M, et al. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature. 1998; 395(6699):297-300. https://doi.org/10.1038/26261
25. Orgera, J. SARSNTdb database: Factors affecting SARS-CoV-2 sequence conservation. Frontiers Virology. 2022; 2:1028335. https://doi.org/10.3389/fviro.2022.1028335
26. Yue K, Yao B, Shi Y, Yang Y, Qian Zh, et al. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity. Biochemical and Biophysical Research Communications. 2022; 601:129-136. https://doi.org/10.1016/j.bbrc.2022.02.068
27. Gorkhali R, Koirala P, Rijal S, Mainali A, Baral A, et al. Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins. Bioinformatics and Biology Insights. 2021; 15. https://doi.org/10.1177/11779322211025876
28. Zeng H, Gao X, Xu G, Zhang Sh, Cheng L, et al. SARS-CoV-2 helicase NSP13 hijacks the host protein EWSR1 to promote viral replication by enhancing RNA unwinding activity. Infectious Medicine. 2022; 1(1):7-16. https://doi.org/10.1016/j.imj.2021.12.004
29. Chen J, Wang Qi, Malone B, Llewellyn E, Pechersky Y, et al. Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication–transcription complex. Nature Structural & Molecular Biology. 2022; 29:250-260. https://doi.org/10.1038/s41594-022-00734-6
30. Khalili Yazdi A, Pakarian P, Perveen S, Hajian T, Santhakumar V, et al. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infectious Diseases. 2022; 8(8):1533-1542. https://doi.org/10.1021/acsinfecdis.2c00165
31. Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. Journal of Clinical Medicine. 2020; 9:1225. https://doi.org/10.3390/jcm9041225
32. Wu A, Peng Y, Huang B, Ding X, Wang X, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020; 27:325-328.https://doi.org/10.1016/j.chom.2020.02.001
33. Majumdar S, Sarkar R. Mutational and phylogenetic analyses of the two lineages of the Omicron variant. Journal of Medical Virology. 2021; 94(5):1777-1779. https://doi.org/10.1002/jmv.27558
34. Kopecky-Bromberg SA, Martínez-Sobrido L, Frieman M, Baric RA, Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. Journal of Virology. 2007; 81:548-557. https://doi.org/10.1128/jvi.01782-06
35. Chan JF, Kok KH, Zhu Zh, Chu H, To KK,. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections. 2020; 9(1):221-236. https://doi.org/10.1080/22221751.2020.1719902
36. Abulsoud AI, El-Husseiny HM, El-Husseiny AA, El-Mahdy HA, Ismail A, et al. Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions. Biomedicine & Pharmacotherapy. 2023; 157:113977. https://doi.org/10.1016/j.biopha.2022.113977
37. Brinkac L, Diepold S, Mitchell S, Sarnese S, Kolakowski LF, et al. SARS-CoV-2 Delta variant isolates from vaccinated individuals. BMC Genomics. 2022; 23:417. https://doi.org/10.1186/s12864-022-08652-z
38. Su Y, Anderson DE, Young BE, Linster M, Zhu F, et al. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2. mBio. 2021; 11(4): 01610-20. https://doi.org/10.1128/mbio.01610-20
39. Gorkhali R, Koirala P, Rijal S, Mainali A, Baral A, Bhattarai HK, et al. Structure and function of major SARS-CoV-2 and SARS-CoV proteins. Bioinformatics and Biology Insights. 2021; 15. https://doi.org/10.1177/11779322211025876
40. Romano M, Ruggiero A, Squeglia F, Maga G, Berisio R. A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells. 2020; 9(5):1267. https://doi.org/10.3390/cells9051267
41. Peacock T, Penrice-Randal R, Hiscox J, Barclay W. et al. SARS-CoV-2 one year on: evidence for ongoing viral adaptation. Journal of General Virology. 2021;102(4). https://doi.org/10.1099/jgv.0.001584
42. Lin, Sh.; Chen, H.; Chen, Z.; Yang, F.; Ye, Fe. et al. Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity. Nucleic Acids Research. 2021;. 49(9):5382-92. https://doi.org/10.1093/nar/gkab320
43. Pillon M, Frazier M, Dillard L, Williams J, Kocaman S. et al. Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics. Nature Communications. 2021; 12(1):636. https://doi.org/10.1038/s41467-020-20608-z
44. https://github.com/cov-lineages/pango-designation/issues/1470
45. Darooneh A, Przedborski M, & Kohandel M. A novel statistical method predicts mutability of the genomic segments of the SARS-CoV-2 virus. QRB Discovery. 2022; 3:E1. https://doi:10.1017/qrd.2021.13